APDN insider filings
APPLIED DNA SCIENCES INC — 3 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-27. Screen APDN transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for APDN between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — APPLIED DNA SCIENCES INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-03-27 | 4 | Shorrock Clay — Chief Legal Officer | Grant/award (A): 91,667 @ $0 · Grant/award (A): 98,039 (derivative) @ $0 · Grant/award (A): 1,961 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | Jantzen Beth — Chief Financial Officer | Grant/award (A): 91,667 @ $0 · Grant/award (A): 98,039 (derivative) @ $0 · Grant/award (A): 1,961 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | Murrah Judith — CIO and COO | Grant/award (A): 99,306 @ $0 · Grant/award (A): 98,039 (derivative) @ $0 · Grant/award (A): 10,294 (derivative) @ $0 | EDGAR |
Recent 8-K events — APPLIED DNA SCIENCES INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-02 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K/A | 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-06-03 | 8-K/A | 3.02 — Unregistered Sales of Equity Securities | EDGAR |
| 2026-05-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Registration filings — APPLIED DNA SCIENCES INC
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-298025 (S-1) — latest: Initial registration (S-1), filed 2026-08-05
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=APDN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →